Navigation Links
Sandia completes depleted uranium study

Sandia National Laboratories has completed a two-year study of the potential health effects associated with accidental exposure to depleted uranium (DU) during the 1991 Gulf War.

The study, "An Analysis of Uranium Dispersal and Health Effects Using a Gulf War Case Study," performed by Sandia scientist Al Marshall, employs analytical capabilities used by Sandia's National Security Studies Department and examines health risks associated with uranium handling.

U.S. and British forces used DU in armor-piercing penetrator bullets to disable enemy tanks during the Gulf and Balkan wars. DU is a byproduct of the process used to enrich uranium for use in nuclear reactors and nuclear weapons. During the enrichment process, the fraction of one type of uranium (uranium-235) is increased relative to the fraction found in natural uranium. As a consequence, the uranium left over after the enrichment process (mostly uranium-238) is depleted in uranium-235 and is called depleted uranium.

The high density, low cost, and other properties of DU make it an attractive choice as an anti-tank weapon. However, on impact, DU particulate is dispersed in the surrounding air both within and outside the targeted vehicle and suspended particulate may be inhaled or ingested. Concerns have been raised that exposure to uranium particulate could have serious health problems including leukemia, cancers, and neurocognitive effects, as well as birth defects in the progeny of exposed veterans and civilians.

Marshall's study concluded that the reports of serious health risks from DU exposure are not supported by veteran medical statistics nor supported by his analysis. Only a few U.S. veterans in vehicles accidentally struck by DU munitions are predicted to have inhaled sufficient quantities of DU particulate to incur any significant health risk. For these individuals, DU-related risks include the possibility of temporary kidney damage and about a 1 percent chance of fatal c ancer.

Several earlier studies were carried out by the U.S. Department of Defense, by University Professors Fetter (University of Maryland) and von Hippel (Princeton), and by an Army sponsored team from Pacific Northwest National Laboratories and Los Alamos National Laboratory.

The conclusions from the Sandia study are consistent with these earlier studies. The Sandia study, however, also includes an analysis of potential health effects of DU fragments embedded as shrapnel in the bodies of some U.S. veterans. The Sandia study also looked at civilian exposures in greater detail, examined the potential risk of DU-induced birth defects in the children of exposed individuals, and provided a more detailed analysis of the dispersion of DU following impact with a number of targeted vehicles.


For a full copy of the report, download the following pdf file from : "An Analysis of Uranium Dispersal and Health Effects Using a Gulf War Case Study"


Source:DOE/Sandia National Laboratories

Related biology news :

1. Sandia work launched on space shuttle shows live cells influence growth of nanostructures
2. Sandia research to focus on early detection of harmful algal blooms
3. Sandia researchers discover way to see how a drug attaches to a cell
4. Sandia researchers take new approach to studying how cells respond to pathogens
5. Worlds largest rainforest drying experiment completes first phase
6. Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses
7. LIAI completes worlds most comprehensive analysis on influenza virus data
8. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
9. Canadian youth 4th highest in international obesity study
10. Frog peptides block HIV in lab study
11. Experimental shingles vaccine proves effective in nationwide study
Post Your Comments:

(Date:11/12/2015)...  Arxspan has entered into an agreement with ... use of its ArxLab cloud-based suite of biological ... will support the institute,s efforts to electronically manage ... internally and with external collaborators. The ArxLab suite ... Institute,s electronic laboratory notebook, compound and assay registration, ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... , November 27, 2015 ... Growing popularity of companion diagnostics is ... cancer biomarkers market with pharmaceutical companies and ... companion diagnostic tests. . ... Complete report on global cancer biomarkers ...
(Date:11/26/2015)... November 26, 2015 --> ... specializing in imaging technologies, announced today that it has received ... of the Horizon 2020 European Union Framework Programme for Research ... clinical trial in breast cancer. , --> ... --> --> The study aims ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... , November 25, 2015 Studies ... and human plaque and pave the way for more effective ... in cats     --> ... commonly diagnosed health problems in cats, yet relatively little was ... Two collaborative studies have been conducted by researchers from the ...
Breaking Biology Technology: